Epidemiologic Characterization of Heart Failure with Reduced or Preserved Ejection Fraction Populations Identified

Rishi J Desai1, Mufaddal Mahesri1, Kristyn Chin1

  • 1Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital & Harvard Medical School, Boston, Mass.

Insights

A new claims-based model accurately predicts heart failure subtypes, distinguishing between reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF) in older adults. This model aids in understanding patient characteristics and outcomes for heart failure management.

Area of Science:

  • Cardiology
  • Health Informatics
  • Epidemiology

Background:

  • Administrative claims lack ejection fraction data for heart failure patients.
  • A validated claims-based model was developed to predict ejection fraction subtype.

Purpose of the Study:

  • To apply a claims-based model to distinguish between heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF).
  • To analyze patient characteristics and outcomes based on the predicted ejection fraction subtype.

Main Methods:

  • Identified 3,134,414 US Medicare heart failure patients aged 65+.
  • Applied a claims-based model to classify patients into HFrEF or HFpEF.
  • Followed patients for worsening heart failure events or all-cause mortality.

Main Results:

  • 6.4% of patients were classified as HFrEF.
  • HFrEF patients were more likely male and younger, with higher rates of myocardial infarction.
  • HFpEF patients had higher rates of hypertension; one-year composite endpoint incidence was 42.6% for HFrEF and 36.9% for HFpEF.

Conclusions:

  • The claims-based model successfully replicated known differences in patient characteristics between HFrEF and HFpEF.
  • The model aids in understanding outcomes, including higher cardiovascular mortality in HFrEF and noncardiovascular mortality in HFpEF.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.3K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
171
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
424
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
464
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
114
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
254